Adumbrations Of AducanumabIs the FDA too lax? Do bears go to the bathroom in spotless marble-floored lavatories? Is the Pope an Anabaptist?Adumbrations Of Aducanumab
In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s DrugThe agency faced criticism for approving Aduhelm for all Alzheimer’s patients. The new label recommends that the drug be given only to patients with mild symptoms.In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug
'Some Hope Is Better Than Having No Hope' · The New York Times'Some Hope Is Better Than Having No Hope' · The New York Times
Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budgetDespite unproven efficacy, Biogen set the drug’s list price at $56,000 per year.Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget
Spotify – A New Alzheimer's Drug Brings Hope and Controversy - The Journal. | Podcast on SpotifySpotify – A New Alzheimer's Drug Brings Hope and Controversy - The Journal. | Podcast on Spotify